Cervical cancer ranks fourth among global women’s malignancies, after breast, lung and colorectal cancer. Its incidence and mortality rates are higher in middle- and low-income countries, despite efforts in screening and anti-HPV vaccination. Tertiary unit hospitals across the country receive many women in advanced stages, who require a multidisciplinary approach. We describe a case series of cervical cancers diagnosed in the University Emergency Hospital Bucharest, Romania, between 2021 and 2026. The demographic profile and patients’ details were obtained from the hospital information system and archival case files after obtaining the informed consent from the patients. The H&E and relevant IHC slides along with histopathology reports of the included cases were analyzed and studied. Immunohistochemistry was helpful in the confirmation of the subtypes and in diagnosing HPV-associated cases.
Cosma et al. (Thu,) studied this question.